Goutham Narla
Gründer bei Rappta Therapeutics Oy
Profil
Goutham Narla is the Chief Scientific Officer and founder of Rappta Therapeutics Oy, which is founded in 2019.
Dr. Narla is also the founder of Dual Therapeutics LLC.
Aktive Positionen von Goutham Narla
| Unternehmen | Position | Beginn |
|---|---|---|
Rappta Therapeutics Oy
 Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Gründer | 20.03.2019 |
Ehemalige bekannte Positionen von Goutham Narla
| Unternehmen | Position | Ende |
|---|---|---|
Dual Therapeutics LLC
 Dual Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Dual Therapeutics LLC develops novel therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. The company was founded in 2013 and is headquartered in Cleveland, OH. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Dual Therapeutics LLC
Dual Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Dual Therapeutics LLC develops novel therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. The company was founded in 2013 and is headquartered in Cleveland, OH. | Commercial Services |
Rappta Therapeutics Oy
Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Health Technology |
